sur Viemed Healthcare, Inc. (NASDAQ:VMD)
Viemed Healthcare Reports Strong Q2 2025 Financial Results
Viemed Healthcare, Inc. has announced its financial results for Q2 2025, marking a successful quarter. The company's net revenues reached $63.1 million, a 14.7% increase from Q2 2024. Net income also surged to $3.2 million, a 115.1% rise year-over-year. Adjusted EBITDA improved by 11.5% to $14.3 million.
The company repurchased 270,061 shares for $1.8 million. Patient counts for ventilator and PAP therapy increased by 11.4% and 51.4%, respectively, over the previous year. With $20.0 million in cash and $55 million in credit, Viemed maintains a robust financial position.
The recent acquisition of Lehan's Medical Equipment promises to boost full-year revenue and Adjusted EBITDA, with increased guidance reflecting anticipated synergies.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Viemed Healthcare, Inc.